Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Immunopharmacol Immunotoxicol ; 43(6): 790-798, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34618622

ABSTRACT

AIM: Demyelination and subsequent remyelination are well-known mechanisms in multiple sclerosis (MS) pathology. Current research mainly focused on preventing demyelination or regulating the peripheral immune system to protect further damage to the central nervous system. However, information about another essential mechanism, remyelination, and its balance of the immune response within the central nervous system's boundaries is still limited. MATERIALS AND METHODS: In this study, we tried to demonstrate the effect of the recently introduced Janus kinase (JAK)-signal transducer and activator of transcription (STAT) inhibitor, tofacitinib, on remyelination.Demyelination was induced by 6-week cuprizone administration, followed by 2-week tofacitinib (10, 30, and 100 mg/kg) treatment. RESULTS: At the functional level, tofacitinib improved cuprizone-induced decline in motor coordination and muscle strength, which were assessed by rotarod and hanging wire tests. Tofacitinib also showed anti-inflammatory effect by alleviating the cuprizone-induced increase in the central levels of interferon-γ (IFN-γ), interleukin (IL)-6, IL-1ß, and tumor necrosis alpha (TNF-α). Furthermore, tofacitinib also suppressed the cuprizone-induced increase in matrix metalloproteinases (MMP)-9 and MMP-2 levels. Additionally, cuprizone-induced loss of myelin integrity and myelin basic protein expression was inhibited by tofacitinib. At the molecular level, we also assessed phosphorylation of STAT-3 and STAT-5, and our data indicates tofacitinib suppressed cuprizone-induced phosphorylation in those proteins. CONCLUSION: Our study highlights JAK/STAT inhibition provides beneficial effects on remyelination via inhibition of inflammatory cascade.


Subject(s)
Chelating Agents/toxicity , Cuprizone/toxicity , Janus Kinase Inhibitors/pharmacology , Myelin Sheath/drug effects , Piperidines/pharmacology , Pyrimidines/pharmacology , Remyelination/drug effects , Animals , Dose-Response Relationship, Drug , Female , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/metabolism , Mice , Mice, Inbred C57BL , Muscle Strength/drug effects , Muscle Strength/physiology , Myelin Sheath/metabolism , Myelin Sheath/pathology , Remyelination/physiology
2.
Behav Brain Res ; 392: 112692, 2020 08 17.
Article in English | MEDLINE | ID: mdl-32479847

ABSTRACT

Numerous studies have investigated the role of agmatine in the central nervous system and indicated neuroprotective properties. In addition to its potent antioxidant effects, agmatine is an endogenous neuromodulator and has wide spectrum molecular actions on different receptor subtypes (NMDA, Imidazoline 1-2, alpha-2 adrenoreceptor, 5-HT2a, 5-HT3) and cellular signaling pathways (MAPK, PKA, NO, BDNF). Although the neuroprotective effects of agmatine demonstrated in experimental Parkinson's disease model, the effects of agmatine with the aspect of neuroplasticity and possible signaling mechanisms behind agmatine actions have not been investigated. Herein, in this study, we investigated the role of the of agmatine on rotenone-induced Parkinson's disease model. Agmatine at the dose of 100 mg/kg i.p., was mitigated oxidative damage and alleviated motor impairments which were the results of the rotenone insult. Additionally, agmatine decreased neuronal loss, tyrosine hydroxylase immunoreactivity and increased cREB, BDNF and ERK1/2 expression in the striatum, which are crucial neuroplasticity elements of striatal integrity. Taken together, the present study expands the knowledge of molecular mechanisms behind neuroprotective actions of agmatine in Parkinson's disease, and as far as we have known, this is the first study to delineate agmatine treated activation of cellular pathways which are important elements in neuronal cell survival.


Subject(s)
Agmatine/pharmacology , Parkinson Disease/drug therapy , Agmatine/metabolism , Animals , Apoptosis/drug effects , Brain/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Cell Survival/drug effects , Corpus Striatum/metabolism , Cyclic AMP Response Element-Binding Protein/metabolism , Disease Models, Animal , MAP Kinase Signaling System/drug effects , Male , Neuronal Plasticity/drug effects , Neurons/metabolism , Neuroprotection/drug effects , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Parkinson Disease/metabolism , Rats , Rats, Sprague-Dawley , Rotenone/pharmacology , Signal Transduction/drug effects
3.
J Chem Neuroanat ; 88: 41-45, 2018 03.
Article in English | MEDLINE | ID: mdl-29126816

ABSTRACT

The aim of this study is to investigate the effects of spermine and the passive avoidance learning on hippocampus following transient cerebral ischemia in the chicks. The study is composed of the pure control (CG), sham (SG) and experimental groups (n=20). Experimental groups (ischemia group, IG and ischemia-spermine group, ISG) were exposed to ischemia for 20min whereas the SG was exposed to sham operation and CG group was not exposed to any operation. Passive avoidance learning (PAL) was applied to the half number of the subjects in each group. Both before and after 7days from the ischemia, operated animals were taken to PAL and then they were sacrificed. Total numbers of neurons in the hippocampus were stereologically estimated using Cresyl violet stained sections. We detected that number of neurons was increased following PAL and especially spermine treatment. According to our results, we suggested that spermine may reduce the deleterious effects of the ischemia by causing to increase in the neuronal number and so, it may be slightly supportive to the PAL.


Subject(s)
Avoidance Learning , Brain Ischemia/pathology , Brain/drug effects , Neuroprotective Agents/pharmacology , Pyramidal Cells/drug effects , Spermine/pharmacology , Animals , Brain/pathology , Chickens , Pyramidal Cells/pathology
4.
J Craniomaxillofac Surg ; 44(9): 1327-32, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27527680

ABSTRACT

The purpose of this study is to investigate the potential of the systemic administration of different doses of rosuvastatin (RSV) on autogenous grafted critical-sized cortical bone defects. Twenty-four rats were divided into three groups: Group C (control), Group RSV-2 and Group RSV-5. A 5-mm diameter critical-size defect was created in the calvarium of each animal. In Group C, the defect was filled by autogenous graft only and rats were given saline solution with oral gavage for 28 days. In Group RSV-2 defects were filled with autogenous graft and rats were given 2 mg/kg rosuvastatin with oral gavage for 28 days. In Group RSV-5 defects were filled with autogenous graft and rats were given 5 mg/kg rosuvastatin with oral gavage for 28 days. All animals were euthanized at 28 days postoperative. Stereologic and micro-CT analyses were performed. New bone area (NBA) and connective tissue volumes were measured. Stereologic analysis showed that Group RSV-5 and RSV-2 had significantly more new bone at 4 weeks compared with group C. Connective tissue volumes were also significantly higher in RSV applicated groups. New bone and connective tissue volumes' difference were not statistically significant between RSV groups. Micro-CT results were similar with stereologic analyses. Orally administered RSV enhances bone regeneration in critical size calvarial rat defects filled with autogenous graft furthermore possible inflammatory effect should be investigated.


Subject(s)
Bone Regeneration/drug effects , Rosuvastatin Calcium/administration & dosage , Rosuvastatin Calcium/pharmacology , Skull/surgery , Wound Healing/drug effects , Administration, Oral , Animals , Disease Models, Animal , Rats , Rats, Wistar , Skull/diagnostic imaging , X-Ray Microtomography
5.
Histol Histopathol ; 31(5): 461-8, 2016 May.
Article in English | MEDLINE | ID: mdl-26661935

ABSTRACT

This paper reviewed possible health effects from exposure to low levels of electromagnetic field (EMF) in children, arising from electrical power sources and mobile phones. Overall, the information about effects on developmental processes and cognitive functions is insufficient and further research on children and adolescents is critically needed. New research approaches are required focused on the effects on the developmental processes of children exposed to electromagnetic fields, using consistent protocols. When the current data were considered in detail, it was noted that children's unique vulnerabilities make them more sensitive to EMFs emitted by electronics and wireless devices, as compared to adults. Some experimental research shows a neurological impact and exposure in humans may lead to the cognitive and behavioral impairments. Because of the proliferation of wireless devices, public awareness of these dangers now is important to safeguard children's future healthy brain development.


Subject(s)
Central Nervous System/radiation effects , Electromagnetic Fields/adverse effects , Adolescent , Cell Phone , Child , Humans
6.
Ren Fail ; 37(8): 1379-83, 2015.
Article in English | MEDLINE | ID: mdl-26365794

ABSTRACT

OBJECTIVE: In this study, we aimed to investigate the effect of diclofenac sodium (DS) and melatonin (MEL) on kidney of the prenatally administered rats. MATERIALS AND METHODS: Pregnant rats were divided into the control, physiological saline, DS, and DS + MEL groups. All injections were given beginning from the 5th day after mating to the 15th day of the pregnancy. Physical dissector and Cavalieri principle were used to estimate the numerical density and total number of glomeruli and the volumetric parameters of kidney, respectively. RESULTS: Our stereological results indicated that DS application during the pregnancy lead to decrease in the mean volume, numerical density, and total number of the glomeruli (p < 0.05). In addition, we determined that usage of the MEL with the DS caused increases in the mean volume, numerical density, and total number of the glomeruli (p < 0.05). So, there was no significant difference in terms of the any parameter between the CONT and DS + MEL groups (p > 0.05). Light microscopic investigation showed congestion in blood vessels and shrinkage of the Bowman's space in the DS group. Moreover, there was degeneration in nephrons including glomerulosclerosis and tubular defects, and an increase in the connective tissue in the kidneys of the DS-treated group. However, usage of the MEL with the DS caused preventing of these pathological alterations in the kidney. DISCUSSION: We suggested that DS might lead to adverse effects in the kidneys of the rats that are prenatally subjected to this drug. Fortunately, these adverse effects can be prevented by the melatonin supplementation.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Antioxidants/pharmacology , Diclofenac/toxicity , Kidney Glomerulus/pathology , Melatonin/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Female , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...